What is Caribou Biosciences Inc?
operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 30.71M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 524,317 shares $47k | 0 |
| 9-12months | 0 | 0 |